This article is more than 5 years old. Information may no longer be current.

Joseph G. Darling appointed as VP, chief operating officer of Interventional Spine

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Interventional Spine recently announced Joseph G. Darling will serve as the company’s next vice president and chief operating officer.

Darling has a 25-year career in the pharmaceutical and medical device business. He most recently served as president of Linvatec Corporation and executive vice president of commercial operations at the CONMED Corporation, according to a company release.

“I am very pleased to take on this expanded role with Interventional Spine as we continue to develop our strategy in the spine market, I look forward to working closely with Walter and the management team to expand our presence and strength in this important market,” Darling said in the release.

Prior to his employment at CONMED Corporation, Darling held various senior management positions with publicly traded global companies, including Smith & Nephew, Wyeth-Ayerst Pharmaceuticals, Baxter International and Abbott Laboratories.

Reference: www.i-spineinc.com.